MYO1D

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MYO1D mutation is significantly associated with the RNA expression of many other genes, with 3,838 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MYO1D-associated genes across cancer lineages are MIR3663, TRDD1, and HARS1. Each is linked with MYO1D in more than 3 cancer types. Because this analysis shows association rather than direction, both MYO1D-to-partner and partner-to-MYO1D results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, MIR3663 grouped by MYO1D-low versus MYO1D-high in HNSC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MYO1D→partner) and Y-score (partner→MYO1D) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCMIR3663 →+0.299+4.327<.001.00934
BRCATRDD1 →+0.682+7.473<.001.00733
UCECHARS1 →+0.236+2.113.001<.00133
UCECRIOK2 →+0.337+1.680<.001<.00133
UCECP4HA1 →+0.593+1.523<.001<.00133
CESCRNU6-1191P →+0.806+4.103<.001.00232
Each partner links to its Q-omics profile. Showing the 6 strongest of 3,838 associations by consensus.

MIR3663 by MYO1D expression — HNSC

Box plot of MIR3663 in MYO1D-low vs MYO1D-high samples in HNSC.

Explore this box plot interactively →

Exploration